Author:
Kotzur Rebecca,Stein Natan,Kahlon Shira,Berhani Orit,Isaacson Batya,Mandelboim Ofer
Funder
Israel Ministry of Innovation Science & Technology
Israel Science Foundation
DKFZ
Horizon 2020 Marie Skłodowska-Curie Actions
German Israeli Foundation for Scientific Research and Development
Reference45 articles.
1. The rise of allogeneic natural killer cells as a platform for cancer immunotherapy: recent innovations and future developments;Veluchamy;Front. Immunol.,2017
2. The NK-92 cell line—30 years later: its impact on natural killer cell research and treatment of cancer;Klingemann;Cytotherapy,2023
3. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells;Gong;Leukemia,1994
4. Genome-wide analyses and functional profiling of human NK cell lines;Gunesch;Mol. Immunol.,2019
5. Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT;Yoneda;Leukemia,1992